NEXT CBD, INC.
PORT RICHEY, FLORIDA

Our CBD is sourced from agricultural hemp. We proudly make all our products in the USA. The demand for CBD-containing products is intense, global, and rapidly increasing. In fact, demand greatly exceeds current reserves, and what is available is generally of questionable or substandard quality. nextCBD will supply the growing worldwide demand for CBD with standardized products meeting Good Agricultural Practices (GAP), Good Manufacturing Practices (GMP), U.S. Food and Drug Administration (FDA), Environment, Health and Safety (EHS), and Kosher standards. To accomplish this, the Company adheres to strict operational protocols at each stage of product manufacture. This commitment positions nextCBD as the world leader in CBD standardization and quality. While no statement made about any nextCBD product has yet been evaluated by the U.S. Food and Drug Administration, our quality standards nevertheless have worked for years to make credible, science-based CBD products a reality. These efforts have led to the discovery and refinement of breakthrough methods for producing CBD with maximum Total Bioavailability. , ordinary CBD products are of limited use. nextCBD’s vastly superior Total Bioavailability multiplies the strength of our products far beyond the reach of competitors nextCBD’s vastly superior Total Bioavailability multiplies the strength of our products far beyond the reach of competitors. The profound advances made by doing credible science have positioned us to be the global leader in setting industry standards for quality, performance and Total Bioavailability. The implications of our advances for transforming CBD use are beyond calculation. Visiting Scholar, Giant Panda Conservation and Research Center, Peking University, China discovered the key plant-derived factor necessary for successful Giant Panda reproduction, the basis to the captive breeding program that has elevated the species out of Endangered Species status) President, Chief Marketing Officer and Chief Innovation Officer, Diageo (one of the largest marketing firms in the world) Masters of Business Administration, Wharton School of Business, University of Pennsylvania CNBC NEXT — 2014 (awarded to the “next generation” of trailblazers deemed instrumental to reshaping business, finance, science and technology over the next 25 years) President, G. Angel & Associates, Inc. (a leading advanced estate planning and tax specialty firm 31 year career with Merck (VP of Operations at Asia Pacific, VP Operations at Human Health. SVP Global Business Services) Accomplished senior business executive with broad international experience and a proven track record of leading complex organizations, developing strategies, implementing change and effectively executing to achieve strategic and operational results Executive Business Consultant and Advisor  focused on helping businesses develop and implement strategic growth plans, as well as collaborating with them to increase their efficiency and effectiveness and achieve improved operating results Business Leader capable of driving sustainable change, steer international growth and deliver efficiencies across the supply chain PLD in Business Leadership at Harvard Business School; YMP Business Management at INSEAD, France and B.Sc. in Electrical Engineering at University of Engineering and Technology, Lahore Extensive experience in commercial, administrative and federal government litigation and administrative matters, including matters before the Food and Drug Administration, the Federal Trade Commission and various federal courts. significantly amplifies CBD absorption into the bloodstream and achieves the desired response by the body. This key aspect of nextCBD products helps to ensure predictable and consistent results. The Company’s ability to produce CBD with our patented bio-enhancement technology will fulfill largely unmet needs in the nutraceutical, dietary supplement, and beverage industries. nextCBD has created a unique, proprietary hemp cultivar that is exceptional for its copious yield of CBD. The Company has also developed innovative and patented technologies that dramatically reduce the time needed for making CBD products. Our world-renowned scientists have worked for years to make credible, science-based CBD products a reality. These efforts have led to the discovery and refinement of breakthrough methods for producing CBD with maximum blood stream. Only of fraction of what gets there yields any effects. Without efficient Total Bioavailability, CBD products are of limited use strength of our products far beyond the reach of competitors. The profound advances made by doing credible science have positioned us to be the global leader in setting industry standards for quality, performance and Total Bioavailability. The implications of our advances for transforming CBD use are beyond calculation. nextCBD products are NOT medical products in any way, and nothing herein is to be construed as medical advice. No statement made about any nextCBD product has been evaluated by the U.S. Food and Drug Administration. nextCBD products are not intended to diagnose, treat, cure, or prevent any disease [U.S. 21 C.F.R. 101.93(c)]. As with any dietary supplement, we recommend consulting with your healthcare provider prior to taking nextCBDCBD supplements.